跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 620 条关于
“SGLT1/SGLT2”
全部
620
临床试验
418
药物
12
机构
0
资讯
190
去年
FDA Advisory Committee Rejects Zynquista for Type 1 Diabetes and Chronic Kidney Disease
去年
FDA Advisory Committee Rejects Zynquista for Type 1 Diabetes and Chronic Kidney Disease
2年前
Sotagliflozin Improves Glycemic Control in Type 2 Diabetes Patients on Insulin Therapy
去年
FDA Advisory Committee Rejects Zynquista for Type 1 Diabetes with Chronic Kidney Disease
去年
FDA Advisory Committee Rejects Zynquista for Type 1 Diabetes and Chronic Kidney Disease
去年
Lexicon's SONATA-HCM Phase 3 Trial Design Unveiled at European Cardiology Congress
去年
Lexicon Pharmaceuticals Initiates Phase 3 Trial of Sotagliflozin for Hypertrophic Cardiomyopathy
去年
Sotagliflozin Demonstrates Renal Protective Benefits in Diabetic Kidney Disease: Phase 3 Data
去年
FDA Panel Rejects Sotagliflozin for Type 1 Diabetes with Mild-to-Moderate CKD
2年前
Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes and CKD
第 1 页,共 19 页
上一页
下一页